Physician profile
Brian P Murrell
NPI 1063694859
$10,021.83
in general payments reported to CMS, 2019-2025
49 companies · $2,081 in 2025
The $2,081 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,273 · 2022: $1,960 · 2023: $2,135 · 2024: $2,573 · 2025: $2,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,778 · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,777.85 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,045.49 | 2021-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $1,349.59 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $912.75 | 2021-2025 | |
| Lilly USA, LLC | $800.37 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $594.85 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $369.71 | 2021-2025 | Gvoke Hypopen |
| Corcept Therapeutics | $332.33 | 2021-2025 | Korlym |
| Tandem Diabetes Care, INC. | $302.54 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $296.65 | 2021-2025 | Tepezza, Evenity, Repatha |
| Mannkind Corporation | $255.69 | 2023-2025 | Afrezza |
| Astrazeneca Pharmaceuticals LP | $247.61 | 2021-2023 | Farxiga |
| Beta Bionics, INC. | $246.72 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbvie INC. | $193.79 | 2021-2025 | |
| Radius Health, INC. | $155.96 | 2022-2025 | Tymlos |
| Insulet Corporation | $139.02 | 2023-2024 | Omnipod |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $137.56 | 2023-2025 | Yorvipath |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.91 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Amneal Pharmaceuticals LLC | $117.02 | 2021-2024 | Unithroid |
| Alexion Pharmaceuticals, INC. | $111.37 | 2022-2025 | Strensiq |
| Horizon Therapeutics Plc | $92.58 | 2021-2023 | Tepezza |
| Vivus LLC | $89.41 | 2021-2023 | Qsymia |
| Recordati_rare_diseases_inc. | $85.78 | 2021-2025 | Isturisa, Signifor Lar |
| Bayer Healthcare Pharmaceuticals INC. | $84.57 | 2021-2025 | |
| Ascensia Diabetes Care US INC. | $83.68 | 2023-2024 | |
| Amarin Pharma, INC. | $77.63 | 2021-2022 | |
| Madrigal Pharmaceuticals | $66.43 | 2025 | Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.50 | 2021-2024 | Cycloset |
| Ibsa Pharma INC. | $56.62 | 2021 | |
| Amphastar Pharmaceuticals, INC. | $53.61 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $50.58 | 2024 | Tlando |
| Esperion Therapeutics, INC. | $48.91 | 2021-2022 | |
| Kyowa Kirin, INC. | $40.41 | 2025 | |
| Lifescan, INC. | $37.92 | 2022-2023 | |
| Becton, Dickinson and Company | $34.90 | 2021 | |
| Astellas Pharma US INC | $33.08 | 2025 | Veozah |
| Ionis Pharmaceuticals, INC. | $31.56 | 2025 | Tryngolza |
| Novartis Pharmaceuticals Corporation | $28.07 | 2024 | |
| Acella Pharmaceuticals, LLC | $27.42 | 2024-2025 | NP Thyroid 60 |
| Amryt Pharma Holdings LTD | $26.59 | 2023 | Myalept, Mycapssa |
| Medtronic, INC. | $22.49 | 2021 | |
| Cequr Corporation | $22.10 | 2022-2025 | Cequr Simplicity |
| Embecta Corp. | $19.37 | 2024 | Bd Nano 2nd Gen Pen Needle |
| Theracosbio, LLC | $17.22 | 2024 | Brenzavvy |
| Pfizer INC. | $14.97 | 2022 | |
| Currax Pharmaceuticals LLC | $14.74 | 2021 | |
| Roche Diabetes Care, INC. | $14.49 | 2021 | |
| Silk Road Medical, INC. | $14.47 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Antares Pharma, INC. | $14.15 | 2021 | |
| Grt US Holding, INC. | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Murrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.